Resource Center
This video provides valuable guidance on interpreting changes in the MAGIC Algorithm Probability (MAP) for acute graft versus host disease (aGVHD), emphasizing its significance in effective clinical decision-making. It highlights the importance of MAP results in assessing patient conditions and understanding their potential risks. The series also explores how the use of multiplexed assessment of biomarkers (MAP) can enhance patient care by enabling more tailored treatment strategies. Ultimately, the integration of these biomarkers into clinical practice can lead to improved treatment outcomes for patients facing aGVHD.
This bi-lateral lung transplant recipient is a 65 year-old male patient who received his lung transplant due to end-stage lung disease secondary to non-CF bronchiectasis. The donor and recipient CMV serostatus is D+/R+. The patient’s initial peri-operative course was complicated by difficult explant, primary graft dysfunction, respiratory failure requiring prolonged mechanical ventilation, renal insufficiency and recurrent infectious concerns, including pseudomonas and stenotrophomonas pneumonias.